New biopsy combo could sharpen lung cancer diagnosis
NCT ID NCT07488507
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a freezing biopsy (cryobiopsy) to the standard needle biopsy improves diagnosis of lung cancer that has spread to the chest. About 240 adults with suspicious chest lymph nodes will get both procedures. The goal is to see if the combo finds cancer more accurately and helps guide treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate and safer way to diagnose lung cancer that has spread to the chest, helping doctors choose the right treatment sooner.
- What could go wrong
- This is an early-stage study focused on diagnostic accuracy, not treatment. The added cryobiopsy may not improve results and could carry extra risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Third Military Medical University
RECRUITINGChongqing, Chongqing Municipality, 400038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection